Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. The company employs 24,379 full-time employees. The company went IPO on 2003-12-08. The firm operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long-term and short-term investments. The Other segment is principally engaged in the related medical and hospital business.
How did SBHMY's recent EPS compare to expectations?
The most recent EPS for Sino Biopharmaceutical Limited is $, expectations of $.
How did Sino Biopharmaceutical Limited SBHMY's revenue perform in the last quarter?
Sino Biopharmaceutical Limited revenue for the last quarter is $
What is the revenue estimate for Sino Biopharmaceutical Limited?
According to of Wall street analyst, the revenue estimate of Sino Biopharmaceutical Limited range from $ to $
What's the earning quality score for Sino Biopharmaceutical Limited?
Sino Biopharmaceutical Limited has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Sino Biopharmaceutical Limited report earnings?
Sino Biopharmaceutical Limited next earnings report is expected in 2026-06-24
What are Sino Biopharmaceutical Limited's expected earnings?
Sino Biopharmaceutical Limited expected earnings is $, according to wall-street analysts.
Did Sino Biopharmaceutical Limited beat earnings expectations?
Sino Biopharmaceutical Limited recent earnings of $ expectations.